Broadcom vs. Marvell: Which Custom AI Chip Stock Is the Better Buy?

Broadcom reported fiscal Q3 2026 revenue growth of 86% year over year to $29.6 billion, driven by a 221% increase in AI semiconductor revenue to $16.7 billion, while EPS rose 96% to $3.32. The company forecasts AI-chip revenue of $21.7 billion this quarter and projects $58 billion in fiscal 2026, nearly $115 billion in fiscal 2027, and potentially $230 billion in fiscal 2028. Marvell remains a beneficiary of custom-AI-chip demand, but its 37% revenue growth to $2.74 billion and 45%-50% forward growth outlook trail Broadcom; the article argues Broadcom's lower valuation and estimated 60% 2027 market share make it the more attractive stock.

Analysis

The relevant valuation is not headline AI revenue growth but the durability of hyperscaler ASIC programs after first deployment. AVGO’s advantage is its ability to monetize the full custom-silicon stack—design services, high-speed connectivity and switching—creating materially higher customer switching costs than a standalone chip comparison implies. If internally designed accelerators displace even a modest portion of NVDA GPU spend, AVGO can capture a larger share of each hyperscaler’s AI capex without requiring aggregate AI budgets to rise.

MRVL is more exposed to the competitive downside of ASIC customer concentration: winning a program can drive sharp revenue inflections, but a delayed tape-out, lower production ramp, or customer migration to a second source can create equally sharp estimate resets. Its recent rerating leaves less room for execution slippage, particularly if custom-chip revenue remains design-win driven rather than recurring platform share. The cleaner relative expression is AVGO long/MRVL short, not an outright semiconductor beta trade.

The consensus risk is that vendor forecasts extrapolate hyperscaler build-outs before end-demand monetization is proven. Over the next 1-3 months, investor focus should shift from custom-chip bookings to customer capex guidance, advanced-packaging availability and whether ASIC deployments reduce incremental GPU purchases; a broad AI-capex pause would pressure both names, but AVGO’s diversified software and infrastructure cash flows should cushion the drawdown. Over 6-18 months, successful ASIC adoption is structurally negative for NVDA’s accelerator unit economics, though NVDA retains an advantage where workloads require flexibility and a mature software ecosystem.

Key Decisions for Investors

• Initiate a 6-12 month long AVGO / short MRVL pair, sized beta-neutral. Target 15-25% relative upside from AVGO multiple expansion and MRVL estimate-risk normalization; exit if MRVL discloses a material new hyperscaler production ramp or AVGO’s next earnings call shows custom-silicon growth decelerating below broader AI semiconductor growth.
• Prefer AVGO shares or 9-12 month call spreads over near-dated calls; near-term implied volatility is vulnerable to a post-earnings crush, while the principal catalyst is successive confirmation of customer production ramps over multiple quarters.
• Maintain a watch alert on GOOG and META capex guidance and TSM advanced-packaging commentary. Any reduction in 2027 AI infrastructure budgets, or evidence that packaging constraints are deferring ASIC volume, would invalidate the near-term AVGO overweight and favor taking pair-trade profits.
• For portfolios seeking an AI substitution hedge, modestly underweight NVDA versus AVGO rather than shorting NVDA outright. ASIC share gains can pressure NVDA’s long-run growth and pricing power, but software lock-in and flexible-compute demand make a directional NVDA short high-risk over the next 1-3 months.